| Patent | Date |
|---|
Attenuated human parainfluenza virus, methods and uses thereof
Grant 9,034,343 - Skiadopoulos , et al. May 19, 2 | 2015-05-19 |
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof
App 20130052718 - Skiadopoulos; Mario H. ; et al. | 2013-02-28 |
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 8,367,074 - Skiadopoulos , et al. February 5, 2 | 2013-02-05 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20130023030 - SKIADOPOULOS; Mario H. ; et al. | 2013-01-24 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20120064569 - Murphy; Brian R. ; et al. | 2012-03-15 |
RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
App 20110189232 - Bartlett; Emmalene ; et al. | 2011-08-04 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20110143422 - SKIADOPOULOS; Mario H. ; et al. | 2011-06-16 |
Attenuated parainfluenza virus (PIV) vaccines
Grant 7,951,383 - Murphy , et al. May 31, 2 | 2011-05-31 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,919,301 - Skiadopoulos , et al. April 5, 2 | 2011-04-05 |
Human Parainfluenza Viruses Having Separated P And C Genes
App 20100330120 - Collins; Peter L. ; et al. | 2010-12-30 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,820,181 - Skiadopoulos , et al. October 26, 2 | 2010-10-26 |
Recombinant human metapneumovirus and its use
Grant 7,704,491 - Collins , et al. April 27, 2 | 2010-04-27 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,704,509 - Murphy , et al. April 27, 2 | 2010-04-27 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,632,508 - Schmidt , et al. December 15, 2 | 2009-12-15 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,622,123 - Skiadopoulos , et al. November 24, 2 | 2009-11-24 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20090081728 - Murphy; Brian R. ; et al. | 2009-03-26 |
RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
App 20080286848 - SKIADOPOULOS; Mario H. ; et al. | 2008-11-20 |
Attenuated parainfluenza virus (PIV) vaccines
App 20080096264 - Murphy; Brian R. ; et al. | 2008-04-24 |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
Grant 7,314,631 - Murphy , et al. January 1, 2 | 2008-01-01 |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
Grant 7,250,171 - Tao , et al. July 31, 2 | 2007-07-31 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20070134271 - Skiadopoulos; Mario H. ; et al. | 2007-06-14 |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
Grant 7,208,161 - Murphy , et al. April 24, 2 | 2007-04-24 |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
Grant 7,201,907 - Schmidt , et al. April 10, 2 | 2007-04-10 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
Grant 7,192,593 - Murphy , et al. March 20, 2 | 2007-03-20 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20060099226 - Schmidt; Alexander C. ; et al. | 2006-05-11 |
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
App 20050287540 - Murphy, Brian R. ; et al. | 2005-12-29 |
Recombinant human metapneumovirus and its use
App 20040241188 - Collins, Peter L. ; et al. | 2004-12-02 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040204581 - Skiadopoulos, Mario H. ; et al. | 2004-10-14 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040142448 - Murphy, Brian R. ; et al. | 2004-07-22 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20030082209 - Skiadopoulos, Mario H. ; et al. | 2003-05-01 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
App 20020155581 - Murphy, Brian R. ; et al. | 2002-10-24 |
| 